Glucocorticoids in rheumatoid arthritis: a senescent research agenda on the brink of rejuvenation?
Treatment of rheumatoid arthritis with glucocorticoids remains controversial despite a considerable and growing body of evidence. This chapter focuses on the research agenda in urgent need of execution: to define conclusively the benefit/harm trade-offs and pin down the place of these agents in the treatment cascade.
Boers
Maarten
M
Department of Clinical Epidemiology & Biostatistics, VU University Medical Center, Amsterdam, The Netherlands. keb.info@vumc.nl
D001172:Arthritis, Rheumatoid / Q000175:diagnosis / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D005544:Forecasting; D005938:Glucocorticoids / Q000009:adverse effects* / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D009426:Netherlands; D012107:Research Design; D018570:Risk Assessment; D012720:Severity of Illness Index; D016896:Treatment Outcome
D005938:Glucocorticoids